Is Organon Stock a Good Investment?
Organon Investment Advice | OGN |
- Examine Organon's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Organon's leadership team and their track record. Good management can help Organon navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Organon's business and its evolving consumer preferences.
- Compare Organon's performance and market position to its competitors. Analyze how Organon is positioned in terms of product offerings, innovation, and market share.
- Check if Organon pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Organon's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Organon Co stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Organon Co is a good investment.
Sell | Buy |
Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Organon Stock
Researching Organon's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 85.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 5.05. Organon last dividend was issued on the 12th of November 2024.
To determine if Organon is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Organon's research are outlined below:
| Organon generated a negative expected return over the last 90 days | |
| Over 85.0% of the company shares are owned by institutional investors | |
| On 12th of December 2024 Organon paid $ 0.28 per share dividend to its current shareholders |
Organon uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Organon Co. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Organon's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 15th of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 15th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Organon's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 4.14 B.Organon's profitablity analysis
The company has Net Profit Margin of 0.2 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.25 %, which entails that for every 100 dollars of revenue, it generated $0.25 of operating income.Determining Organon's profitability involves analyzing its financial statements and using various financial metrics to determine if Organon is a good buy. For example, gross profit margin measures Organon's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Organon's profitability and make more informed investment decisions.
Basic technical analysis of Organon Stock
As of the 30th of January, Organon holds the Variance of 4.94, coefficient of variation of (968.29), and Risk Adjusted Performance of (0.08). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Organon, as well as the relationship between them.Organon's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Organon insiders, such as employees or executives, is commonly permitted as long as it does not rely on Organon's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Organon insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Organon's Outstanding Corporate Bonds
Organon issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Organon uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Organon bonds can be classified according to their maturity, which is the date when Organon Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| US68622TAB70 Corp BondUS68622TAB70 | View | |
| US68622TAA97 Corp BondUS68622TAA97 | View |
Understand Organon's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Organon's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (1.36) | |||
| Mean Deviation | 1.75 | |||
| Coefficient Of Variation | (968.29) | |||
| Standard Deviation | 2.22 | |||
| Variance | 4.94 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (1.37) | |||
| Maximum Drawdown | 10.53 | |||
| Value At Risk | (3.79) | |||
| Potential Upside | 3.21 | |||
| Skewness | (0.13) | |||
| Kurtosis | 0.493 |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (1.36) | |||
| Mean Deviation | 1.75 | |||
| Coefficient Of Variation | (968.29) | |||
| Standard Deviation | 2.22 | |||
| Variance | 4.94 | |||
| Information Ratio | (0.14) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (1.37) | |||
| Maximum Drawdown | 10.53 | |||
| Value At Risk | (3.79) | |||
| Potential Upside | 3.21 | |||
| Skewness | (0.13) | |||
| Kurtosis | 0.493 |
Consider Organon's intraday indicators
Organon intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Organon stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 46026.98 | |||
| Daily Balance Of Power | (0.49) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 16.0 | |||
| Day Typical Price | 15.94 | |||
| Price Action Indicator | (0.26) | |||
| Period Momentum Indicator | (0.22) |
Organon Stock media impact
Far too much social signal, news, headlines, and media speculation about Organon that are available to investors today. That information is available publicly through Organon media outlets and privately through word of mouth or via Organon internal channels. However, regardless of the origin, that massive amount of Organon data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Organon news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Organon relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Organon's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Organon alpha.
Organon Corporate Management
| Susan ONeal | Chief Officer | Profile | |
| Rebecca Edwards | Chief Officer | Profile | |
| Rachel Stahler | Executive Officer | Profile | |
| Susanne Fiedler | Executive Officer | Profile | |
| Daniel Karp | Executive Development | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organon Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Organon's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.